Handelsbanken Fonder

Handelsbanken Fonder’s Protagonist Therapeutics PTGX Stock Holding History

Handelsbanken Fonder’s Portfolio PTGX Stock Details PTGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.62M	Buy	21,400 +1,500	+8%	+$157K	0.01%	707
2026 Q1	$2.1M	Hold	19,900	–	–	0.01%	714
2025 Q4	$1.74M	Buy	19,900 +1,000	+5%	+$81.8K	0.01%	802
2025 Q3	$1.26M	Buy	18,900 +1,900	+11%	+$108K	﹤0.01%	913
2025 Q2	$940K	Buy	17,000 +2,600	+18%	+$125K	﹤0.01%	995
2025 Q1	$696K	Sell	14,400 -3,200	-18%	-$134K	﹤0.01%	1100
2024 Q4	$679K	Buy	+17,600	New	+$767K	﹤0.01%	1167

Other funds holding PTGX

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

Torren Management San Diego, California $197M AUM

Marquette Asset Management Minneapolis, Minnesota $776M AUM 23.4% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return